Newsroom
July 23, 2020
In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms (MPNs). Watch the interview.
July 20, 2020
Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature. Researchers from the Long School of Medicine at The University of Texas Health Science Center at San Antonio contributed to the study. Ewing sarcoma is a bone and soft tissue cancer that primarily affects children and adolescents. […]
July 13, 2020
Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.
July 10, 2020
ABC 12 TV in Miami, Fla., aired the Ivanhoe Broadcast News story about research being conducted by Pratap Kumar, PhD, Department of Molecular Medicine, and Darpan Patel, PhD, associate professor of research in the School of Nursing. The researchers decided to test cork tree bark extract, also called Nexrutine, to fight dangerous body inflammation, which […]